New patent for Harm Reduction drug RIVIVE

Annual Drug Patent Expirations for RIVIVE Rivive is a drug marketed by Harm Reduction Therp and is included in one NDA. It is available from one supplier. There is one…

The post New patent for Harm Reduction drug RIVIVE appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog